Literature DB >> 3976440

Epidural monitoring of the intracranial pressure in severe head injury characterized by non-localizing motor response.

H K Nordby, N Gunnerød.   

Abstract

Recent studies on prognostic variables and the intensive care of head injuries enabled us to select 64 patients and administer a standard treatment protocol to prevent secondary brain injury. All the patients were in coma with a flexor motor pattern as the best response between 6 and 24 hours after the accident and/or decompressive surgery. Continuous epidural intracranial pressure (ICP) monitoring was used in all patients to control the effect of positioning, analgetics, hyperventilation and osmotherapy. None of the patients with a normal initial ICP (15 mm Hg or less) developed an ICP increase leading to brain tamponade. A subsequent further rise to 40 mm Hg signified a very high risk of progression towards brain tamponade. The majority of the patients (71%) with a maximum ICP increase of less than 40 mm Hg had an acceptable recovery. After 6-12 months, the outcome in this series of patients was 48% with a good/moderate recovery, 14% with severe deficits and 38% dead/vegetative.

Entities:  

Mesh:

Year:  1985        PMID: 3976440     DOI: 10.1007/bf01413271

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  18 in total

1.  Assessment of Leeds device for monitoring intracranial pressure.

Authors:  N M Dearden; D G McDowall; R M Gibson
Journal:  J Neurosurg       Date:  1984-01       Impact factor: 5.115

2.  Effect of intracranial pressure monitoring and aggressive treatment on mortality in severe head injury.

Authors:  T G Saul; T B Ducker
Journal:  J Neurosurg       Date:  1982-04       Impact factor: 5.115

3.  Differential intracranial pressure in patients with unilateral mass lesions.

Authors:  D D Weaver; H R Winn; J A Jane
Journal:  J Neurosurg       Date:  1982-05       Impact factor: 5.115

4.  Intracranial pressure: to monitor or not to monitor? A review of our experience with severe head injury.

Authors:  R K Narayan; P R Kishore; D P Becker; J D Ward; G G Enas; R P Greenberg; A Domingues Da Silva; M H Lipper; S C Choi; C G Mayhall; H A Lutz; H F Young
Journal:  J Neurosurg       Date:  1982-05       Impact factor: 5.115

5.  Influence of the type of intracranial lesion on outcome from severe head injury.

Authors:  T A Gennarelli; G M Spielman; T W Langfitt; P L Gildenberg; T Harrington; J A Jane; L F Marshall; J D Miller; L H Pitts
Journal:  J Neurosurg       Date:  1982-01       Impact factor: 5.115

6.  Some principles of postoperative epidural pressure monitoring.

Authors:  M Belopavlovic; A Buchthal; J W Beks; H L Journée
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

7.  Outcome in 200 consecutive cases of severe head injury treated in San Diego County: a prospective analysis.

Authors:  S A Bowers; L F Marshall
Journal:  Neurosurgery       Date:  1980-03       Impact factor: 4.654

8.  Prognosis of patients with severe head injury.

Authors:  B Jennett; G Teasdale; R Braakman; J Minderhoud; J Heiden; T Kurze
Journal:  Neurosurgery       Date:  1979-04       Impact factor: 4.654

9.  Brain edema after stroke. Clinical syndrome and intracranial pressure.

Authors:  A H Ropper; B Shafran
Journal:  Arch Neurol       Date:  1984-01

10.  Chart for outcome prediction in severe head injury.

Authors:  S C Choi; J D Ward; D P Becker
Journal:  J Neurosurg       Date:  1983-08       Impact factor: 5.115

View more
  2 in total

1.  Spinal epidural pressure as a less-invasive monitoring of intracranial pressure: report of two cases of encephalitis.

Authors:  Mitsuko Mimura; Yukihiro Kumeta; Kouhei Echizenya
Journal:  J Anesth       Date:  1997-09       Impact factor: 2.078

Review 2.  Intracranial pressure monitoring: fundamental considerations and rationale for monitoring.

Authors:  Randall Chesnut; Walter Videtta; Paul Vespa; Peter Le Roux
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.